Your browser doesn't support javascript.
loading
Accuracy-based proficiency testing for testosterone measurements with immunoassays and liquid chromatography-mass spectrometry.
Cao, Zhimin Tim; Botelho, Julianne Cook; Rej, Robert; Vesper, Hubert.
Afiliación
  • Cao ZT; Wadsworth Center, New York State Department of Health, Albany, NY, United States; College of Arts and Sciences, University at Albany, State University of New York, Albany, NY, United States.
  • Botelho JC; Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Rej R; Wadsworth Center, New York State Department of Health, Albany, NY, United States; School of Public Health, University at Albany, State University of New York, Albany, NY, United States.
  • Vesper H; Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: hvesper@cdc.gov.
Clin Chim Acta ; 469: 31-36, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28288785
ABSTRACT

BACKGROUND:

Accurate testosterone measurements are needed to correctly diagnose and treat patients. Proficiency Testing (PT) programs using modified specimens for testing can be limited because of matrix effects and usage of non-reference measurement procedure (RMP)-defined targets for evaluation. Accuracy-based PT can overcome such limitations; however, there is a lack of information on accuracy-based PT and feasibility of its implementation in evaluation for testosterone measurements.

METHODS:

Unaltered, single-donor human serum from 2 male and 2 female adult donors were analyzed for testosterone by 142 NYSDH-certified clinical laboratories using 16 immunoassays and LC-MS/MS methods. Testosterone target values were determined using an RMP.

RESULTS:

The testosterone target concentrations for the 4 specimens were 15.5, 30.0, 402 and 498ng/dl. The biases ranged from -17.8% to 73.1%, 3.1% to 21.3%, -24.8% to 8.6%, and -22.1% to 6.8% for the 4 specimens, respectively. Using a total error target of ±25.1%, which was calculated using the minimum allowable bias and imprecision, 73% of participating laboratories had ≥3 of the 4 results within these limits.

CONCLUSIONS:

The variability in total testosterone measurements can affect clinical decisions. Accuracy-based PT can significantly contribute to improving testosterone testing by providing reliable data on accuracy in patient care to laboratories, assay manufacturers, and standardization programs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría de Masas / Testosterona / Análisis Químico de la Sangre / Inmunoensayo / Cromatografía Liquida / Límite de Detección Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Chim Acta Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría de Masas / Testosterona / Análisis Químico de la Sangre / Inmunoensayo / Cromatografía Liquida / Límite de Detección Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Chim Acta Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
...